Imagen de perfil
Bimbam
@Klambam
3Año·

Has anyone read news about $IBRX (-7,75 %) or knows what is going on? Almost 300% in one month.

1
7 Comentarios
Imagen de perfil
Yassin@RisingAktie
3Año
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
Imagen de perfil
Bimbam@Klambam
3Año
@RisingAktie Did not dare to buy again 😂
••
Imagen de perfil
Yassin@RisingAktie
3Año
@Klambam I thought the go down again briefly, but then it knew only one direction upwards and I wanted to reduce my buy-in actually and not increase. Well, I'm just now well back in the plus. Could only have been more, if I had decided 1-2 days earlier
••
Imagen de perfil
Bimbam@Klambam
3Año
@RisingAktie yes let's wait and see where the journey goes 💪🏻
•
1
•
Imagen de perfil
Patrick ₿ateman@fastlane
3Año
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
1
•
Imagen de perfil
Nico@itZNico
3Año
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
Imagen de perfil
Bimbam@Klambam
3Año
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
Mostrar respuesta
Únase a la conversación
InscríbaseInicio de sesión